Study wrapper · #903
Effect of semaglutide on hidradenitis suppurativa disease control and quality of life: A case series.
Drayne R, Lyons D, Kirby B, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2026.
DOI: 10.1111/jdv.70614PubMed: 42466886
Editor's note
Semaglutide is the direct subject here, studied for its association with hidradenitis suppurativa outcomes. As an uncontrolled case series with no abstract detail available, the evidence is weak and hypothesis-generating. Worth noting as an emerging off-label signal, but not a basis for firm conclusions.
Plain-language abstract
This case series reports on semaglutide use in patients with hidradenitis suppurativa, describing changes in disease control and quality of life.
Related coverage
Mixed
Hunger pain and its reduction; qualitative insight from people with schizophrenia on semaglutide.
International journal of qualitative studies on health and well-beingn=——2026
Weak / none
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting.
Journal of enzyme inhibition and medicinal chemistryn=——2026
Mixed
Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.
Journal of obstetrics and gynaecologyn=——2026